FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is a pharmaceutical aerosol formulation for use in the administration of medicaments by inhalation, comprising beclometasone dipropionate and a formoterol salt for use in pressurised metered dose inhalers (pMDI's) at certain ratios. Metered dose inhaler and the use of beclomethasone dipropionate in a pharmaceutical aerosol formulation are also described.
EFFECT: co-administration of formoterol fumarate and beclometasone dipropionate by pressurised metered dose inhalers (pMDI's) provides significant advantages in the treatment and control of asthma.
23 cl, 1 dwg, 9 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2561052C2 |
| MEDICINAL AEROSOL COMPOSITIONS | 2002 |
|
RU2294737C2 |
| COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
| PHARMACEUTICAL COMPOSITION OF METERED AEROSOLS CONTAINING ANTIASTHMATIC AGENTS IN FORM OF SUSPENSIONS, SOLUTIONS, EMULSIONS, SOLUTIONS AND EMULSIONS | 2007 |
|
RU2356537C2 |
| INHALATION PARTICLES CONTAINING COMBINATION OF ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENTS | 2015 |
|
RU2697867C2 |
| CRYSTALLINE MICRO PARTICLES OF BETA-AGONIST, COATED WITH FATTY ACID | 2012 |
|
RU2629085C2 |
| AEROSOL FORMULATION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2567040C2 |
| METHOD FOR PREPARING METERED DOSE SPRAYED INHALER FOR TREATING RESPIRATORY DISEASE | 2012 |
|
RU2582218C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
| COMPRESSED AIR METERED-DOSE INHALER CONTAINING A BUFFERED PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2795000C2 |
